BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 26, 2005
View Archived Issues
Infliximab shows promise in the treatment of refractory PUK
Read More
Memory Pharmaceuticals and Amgen sign agreement on PDE10 inhibitors
Read More
Norwood Immunology signs agreement for phase II melanoma vaccine trial
Read More
Companies advance various approaches to avian flu
Read More
Organizations report discovery of agents for heart failure, arrhythmia, etc.
Read More
Repligen in expanded uridine agreement for bipolar disorder
Read More
The Vaccine Company secures funding for phase III AML study of PR1 vaccine
Read More
Novel treatment options for hepatic disorders described in recent patent literature
Read More
Syntonix and Boehringer Ingelheim to optimize therapeutic peptides for inhalation
Read More
Lilly to support study of Corlux to mitigate olanzapine-associated weight gain
Read More
Method to predict/detect age-related macular degeneration reported by the University of Iowa
Read More
Oxycyte produces positive results in preclinical traumatic brain injury study
Read More
Hyzaar 100-12.5 mg now available
Read More
BCY LifeSciences signs letter of intent for business combination with Pipex
Read More
Phase II study of Gabapentin GR completes enrollment
Read More
Recombinant osteoprotegerin shows potential in juvenile Paget's disease
Read More
New mGluR1 antagonist shows promise as an analgesic
Read More
Abbott profiles its new highly selective dopamine D4 receptor agonist
Read More
Blocking P-glycoprotein increases Abeta accumulation
Read More
Bevacizumab improves visual acuity of patients with neovascular AMD
Read More
Clinical evidence supports the use of Evizon in wet AMD
Read More
Trastuzumab significantly improves disease-free survival in early stage HER2-positive breast cancer
Read More
Lurasidone effective in acute exacerbation of schizophrenia
Read More
Cognitive parameters improved with ispronicline in age-associated memory impairment
Read More
CV Therapeutics withdraws ranolazine MAA with plans to resubmit
Read More
Japanese approval for Avelox
Read More
Tostrex launched in Sweden
Read More